People with mild thyroid eye disease benefit from breakthrough treatment
Last year, the U.S. FDA approved Tepezza (teprotumumab) to treat thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards. ...
Nov 16, 2021
0
2
